Sign In
Buy BCDA
$0.87
-0.0256 (-2.84%)
At Close: Jun 03, 2026
– Positive CardiAMP CMI Trial open-label cohort results demonstrated opportunity for locally delivered cell therapy to enhance therapeutic options for patients with severely symptomatic refractory a
BioCardia, Inc. (BCDA) Q1 2026 Earnings Call Transcript
06:20pm, Friday, 15'th May 2026
BioCardia, Inc. (BCDA) Q1 2026 Earnings Call Transcript
BioCardia Reports First Quarter 2026 Business Highlights and Financial Results
08:00am, Friday, 15'th May 2026
SUNNYVALE, Calif., May 15, 2026 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary disease
BioCardia to Host Q1 2026 Financial Results and Corporate Update Conference Call on May 15, 2026
05:10pm, Monday, 11'th May 2026
SUNNYVALE, Calif. , May 11, 2026 (GLOBE NEWSWIRE) -- BioCardia, Inc. [NASDAQ: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, t
BioCardia to Host Q1 2026 Financial Results and Corporate Update Conference Call on May 15, 2026
05:10pm, Monday, 11'th May 2026
SUNNYVALE, Calif., May 11, 2026 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [NASDAQ:BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, t
BioCardia and FDA Align on Helix Transendocardial Delivery Catheter Clearance Pathways
08:00am, Friday, 08'th May 2026
SUNNYVALE, Calif. , May 08, 2026 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary disease
SUNNYVALE, Calif., April 20, 2026 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary dis
Tamboran Farmout Pilot Area and BCDA Acreage for Significant Premium in Acreage Value
08:57am, Monday, 30'th Mar 2026
NEW YORK--(BUSINESS WIRE)--Tamboran Resources Corporation (NYSE: TBN, ASX: TBN): Tamboran Resources Corporation Chief Executive Officer, Mr. Todd Abbott, said: “This transaction represents a signifi
BioCardia Q4 Earnings Call Highlights
03:07am, Thursday, 26'th Mar 2026
BioCardia (NASDAQ: BCDA) executives on Tuesday outlined new clinical data for the company's lead cell therapy program and discussed upcoming regulatory interactions in the U.S. and Japan, while also r
BioCardia, Inc. (BCDA) Q4 2025 Earnings Call Transcript
08:44pm, Tuesday, 24'th Mar 2026
BioCardia, Inc. (BCDA) Q4 2025 Earnings Call Transcript
BioCardia Reports 2025 Business Highlights and Financial Results
04:05pm, Tuesday, 24'th Mar 2026
SUNNYVALE, Calif., March 24, 2026 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary disea
BioCardia to Host 2025 Financial Results and Corporate Update Conference Call on March 24, 2026
07:47pm, Thursday, 19'th Mar 2026
SUNNYVALE, Calif., March 19, 2026 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [NASDAQ:BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases,
BioCardia (NASDAQ:BCDA) Stock Price Down 3.9% – Time to Sell?
02:20am, Thursday, 19'th Mar 2026
Shares of BioCardia, Inc. (NASDAQ: BCDA - Get Free Report) fell 3.9% on Wednesday. The company traded as low as $1.22 and last traded at $1.23. 42,279 shares traded hands during mid-day trading, a dec
SUNNYVALE, Calif., Feb. 10, 2026 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases,
BioCardia Cell Therapy for Ischemic Heart Failure to Progress to Formal Clinical Consultation with Japan PMDA
08:00am, Tuesday, 16'th Dec 2025
SUNNYVALE, Calif., Dec. 16, 2025 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [NASDAQ: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases,
